Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Gorilla-wrestling over east coast gas to follow massive foreign bid

2018-07-01 theage.com.au
The Hong Kong bidder for Australian energy company APA’s gas pipelines may have to offload ownership of critical east coast gas pipelines in order to clinch regulator support for its $13 billion takeover.
530407 EPIC DUETF DUE

0
Gorilla-wrestling over east coast gas to follow massive foreign bid

2018-07-01 smh.com.au
The Hong Kong bidder for Australian energy company APA’s gas pipelines may have to offload ownership of critical east coast gas pipelines in order to clinch regulator support for its $13 billion takeover.
530407 EPIC DUETF DUE

0
Regulators still a hurdle CKI's $13b takeover bid for APA

2018-06-24 theage.com.au
Hong Kong-based infrastructure firm CKI has seen little resistance from the market and shareholders to its $13 billion takeover bid for gas pipeline group APA but there are still stumbling blocks ahead from government regulators.
DUETF DUE

0
Regulators still a hurdle CKI's $13b takeover bid for APA

2018-06-24 smh.com.au
Hong Kong-based infrastructure firm CKI has seen little resistance from the market and shareholders to its $13 billion takeover bid for gas pipeline group APA but there are still stumbling blocks ahead from government regulators.
DUETF DUE

19
APA's largest shareholder UniSuper open to joint takeover bid

2018-06-21 theage.com.au
APA’s largest shareholder UniSuper is open to a partnership with the Hong Kong group bidding $13 billion for the gas pipeline company, describing AustralianSuper's decision to team up with the failed private equity bid for hospital group Healthscope as "rational".
RTPPF RIO RIO TCL RIO RTNTF SYD DUETF TRAUF DUE SYDDF

19
APA's largest shareholder UniSuper open to joint takeover bid

2018-06-21 smh.com.au
APA’s largest shareholder UniSuper is open to a partnership with the Hong Kong group bidding $13 billion for the gas pipeline company, describing AustralianSuper's decision to team up with the failed private equity bid for hospital group Healthscope as "rational".
RTPPF RIO RIO TCL RIO RTNTF SYD DUETF TRAUF DUE SYDDF

0
Drummer and CEO Mick McCormack faces his toughest gig

2018-06-15 theage.com.au
When APA Group boss Michael McCormack retires he hopes to be able to pursue his love of drumming.
INCZY DUETF APA ICPVF IPL DUE

0
Drummer and CEO Mick McCormack faces his toughest gig

2018-06-15 smh.com.au
When APA Group boss Michael McCormack retires he hopes to be able to pursue his love of drumming.
INCZY DUETF APA ICPVF IPL DUE

0
China CK Infrastructure Offers $7.8B For Australian Gas Pipeline Operator

2018-06-13 oilprice
Irina is a writer for the U.S.-based Divergente LLC consulting firm with over a decade of experience writing on the oil and gas industry.
DUETF DUE

0
Victor Li puts his stamp on family empire with US$9.8b M&A

2018-06-13 theedgemarkets
HONG KONG (June 13): Victor Li, who succeeded his famed father last month as head of the CK group of companies, began his tenure with a A$13 billion (US$9.8 billion) bid for Australian gas pipeline operator APA Group Ltd, in what would be the Hong Kong-based conglomerate’s biggest overseas acquisition.
CKHUF HGKGF HGKGY CKHUY DUETF APA DUE

0
Chinese group lobs $13bn offer for APA

2018-06-13 businessnews.com.au
The ownership of two major gas pipelines in Western Australia could change hands after a Chinese consortium proposed a $13 billion takeover of energy infrastructure giant APA Group, one year after the same consortium bought DUET Group, which owns the Dampier to Bunbury gas pipeline.
DUETF APA DUE

0
Victor Li's CKI attempts biggest-ever deal with A$13b APA bid

2018-06-13 malaymail
HONG KONG, June 13 — Hong Kong’s Cheung Kong Infrastructure Holdings Ltd offered A$13 billion (RM39.4 billion) for Australian gas pipelines company APA Group, as new chairman Victor Li starts his tenure attempting the company’s biggest-ever takeover.
1038 HGKGF CKISY HGKGY CKISF DUETF APA DUE

0
APA Group a $13bn Chinese takeover target

2018-06-12 perthnow.com.au
APA Group has opened its books to a Chinese consortium after the energy infrastructure operator received a $13 billion takeover proposal.
DUETF APA DUE

1
Forrest to build NSW's first LNG import terminal at Port Kembla

2018-06-04 theage.com.au
Fortescue Metals chairman Andrew "Twiggy" Forrest’s Australian Industrial Energy will build a floating LNG import terminal in Port Kembla to bring more gas to NSW and Victoria as soon as 2020.
MARUF DUETF DUE

1
Forrest to build NSW's first LNG import terminal at Port Kembla

2018-06-04 smh.com.au
Fortescue Metals chairman Andrew "Twiggy" Forrest’s Australian Industrial Energy will build a floating LNG import terminal in Port Kembla to bring more gas to NSW and Victoria as soon as 2020.
MARUF DUETF DUE

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to ASX:DUE / DUET GROUP on message board site Silicon Investor.

Delisting due to Sarbox cost of compliance Due Diligence - How to Investigate a Stock
DNAPrint (Due Diligence search) Under A Dollar With Earnings Due Out Within 30 Days
Durum Energy---V.DUE DD-CIA Due Diligence Central Intelligence Agency
DIME NEWS u0026 DD (Due Diligence)